News

1st October 2024

Merakris Therapeutics Introduces Dermacyte® AC Matrix: A Lyophilized Amnion Chorion Allograft

5th September 2024

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

9th May 2024

Jonathan Berlent Joins Merakris as SVP, Head of Strategy and Operations

12th March 2024

Favorable Results From Dermacyte® Matrix Research Study Published in March Issue of Journal of Wound Care

Top